Ọrịa shuga ọ bụla maara na amachibidoro ị theụ ọgwụ Glucofage, onye enyeghị ndakọrịta na ọgwụgwọ nke oria consolitant na mbụ.
Ngwá ọrụ a bụ akụkụ nke ìgwè biguanide, na-enye mmetụta hypoglycemic na ụdị shuga 2. N'adịghị ka ọtụtụ ọgwụ hypoglycemic ndị ọzọ, a na-ahapụ Glucofage ka ọ jiri ma okenye ma ụmụaka karịa 10 afọ.
Onye ọrịa na-eche maka ahụike ya mara na iji ọgwụ ọ bụla ekwesịrị ka ya na ndị dọkịta na-aga ya kwurịta banyere ya. Isiokwu a ga - enyere gị aka ịchọpụta ma ị nwere ike ị drinkụ Glucofage na ọgwụ ndị ọzọ, ọ bụrụ na ọ bụ, olee ndị.
Ozi izugbe ọgwụ
Mbadamba ọgwụ ọ bụla nke ọgwụ Glucofage nwere ihe mejupụtara ya - metformin hydrochloride, yana obere ego magnesium stearate, povidone na hypromellose. Ọ dị na ụdị dị iche iche - 500 mg, 850 mg na Glucofage 1000 mg ma ọ bụ Glucofage Long (ogologo oge na-eme).
Ekwenyere ọgwụ a ka ejikọtara ya na ọgwụ insulin na ọgwụ hypoglycemic ndị ọzọ, nke a ga-atụle ma emesịa. Na mgbakwunye, mgbe ị na-a medicationụ ọgwụ na ndị ọrịa buru oke ibu, enwere mbelata nke ahụ.
Nke a na-egosi na site na ekele ndị ọrịa shuga na-enwe. Lyudmila (dị afọ 53): “Hụrụ Glucofage ruo ogologo oge, n'ihi nke a, ọkwa shuga dị, ma bukwa ibu ahụ malitere ịda, nke m na-atụghị anya ya.” Ejikọtara usoro a na ihe na - arụ ọrụ - metformin hydrochloride, nke na - enyere aka ịmị abụba.
Na mbido, ndị okenye nwere ike ị drinkụ ọgwụ ahụ site na 500 ruo 850 mg ruo ugboro atọ n'ụbọchị. Ọkachamara ahụ, dabere na ọdịnaya glucose dị n'ọbara, nwere ike ịbawanye dose nke Glucofage. A na-ahụta usoro mmezi ahụ ka ọ dị site na 1500 ruo 2000 mg, yana ọnụego ya kachasị elu - ihe ruru 3000 mg kwa ụbọchị. A dụrụ ụmụaka ọdụ ka ha wepụta 2000 mg kwa ụbọchị, ha na monotherapy yana yana insulin insulin.
Yabụ, dịka ọgwụ ọgwụ ndị ọzọ, ekwesighi iji Glucophage ma ọ bụrụ na onye ọrịa mamịrị nwere oria ma ọ bụ ọnọdụ ndị a.
- ọgwụ mgbochi na akụkụ nke ọgwụ ahụ;
- nsị imeju na imeju imeju;
- ọghọm nke mmebi akụrụ nke sitere na mmiri akpịrị ịkpọ nkụ, ọrịa, ma ọ bụ ujo;
- ihe ịwa ahụ na nnukwu mmerụ ahụ;
- iburu nwatakịrị na inye nwa ara (anaghị atụ aro ya);
- nyocha nke redioisotope na x-ray (n’ime ụbọchị 2 tupu mgbe emesịrị);
- lactic acidosis, ketoacidosis, precca ọrịa mamịrị na coma;
- nri nwere obere kalori ma ọ bụ nri adịghị edozi;
- nsị ethanol na egbu egbu egbu egbu.
N'etiti nsogbu dị iche iche na-emebi emebi, ihe ndị kachasị na-akpata bụ nsogbu nri nri na imebi ịnụ ụtọ ihe ụtọ. Ọrịa afọ, afọ ntachi, flatulence na ọgbụgbọ metụtara ahụ na-eme ka akụkụ ahụ nke ọgwụ ahụ pụta, yabụ mgbe ụbọchị 10-14 gachara akara niile ndị a.
N'oge ụfọdụ, ọnya anụ ahụ, itching, mmepe nke lactic acidosis, ụkọ vitamin B12, yana imeju na ịba ọcha n'anya.
Nchịkọta ego ejikọtara ọnụ
A maara nke ọma Glucophage dị ka ọgwụ "capricious" nke chọrọ nlebara anya pụrụ iche mgbe ị na-eji ọgwụ ndị ọzọ. Mana nke mbu, ndi oria shuga kwesiri ịkwụsị omume ojoo. Ndị ọrịa na-a pụ ọgwụ kwesịrị ichefu banyere mmanya, ma ọ bụ biya ma ọ bụ ihe ọ -ụ alcoholụ na-adịghị mma. X Withụ mmanya ethanol, enwere ike ịbelata lactic acidosis, ọkachasị ndị ọrịa nwere ọrịa imeju na nri na-edozi ahụ.
Ekwesiri iburu n'uche na mmanya enweghi ike ijikọ ya na ọrịa mellitus nke na-eme ka ike gwụ metabolism. Maka ndị ọrịa na-enweghị ike ịhapụ ị alcoholụ mmanya, ndị dọkịta na-atụ aro ka ha zere ụbọchị ma ọ dịkarịa ala ụbọchị atọ ka usoro ọgwụgwọ Glucofage gasịrị. Enwekwara ụfọdụ ọgwụ nwere ethanol, yabụ amachibidoro iji ha hypoglycemic ọgwụ n'otu oge.
Of theụ ọgwụ ahụ ga-akwụsị ma ọ bụrụ na onye nwere ọrịa mamịrị daa ọrịa akụrụ ga-enyocha nyocha nke redio site na iji ndị na-eme ihe na ayodiin.
Will gha ichefu banyere iwere Glucofage nwa oge, ọbụlagodi ụbọchị abụọ tupu ọmụmụ ihe ahụ, ma ọ bụrụ na achọpụtaghị ọnya akụrụ.
Ọgwụ na-achọ ịkpachara anya
Enwere ụfọdụ njikọ ndị ọrụ na-emetụta mmetụta ọgwụgwọ glucophage. Ekpebisiri ike site na njirisi dịka hyperglycemic na hypoglycemic mmetụta nke ọgwụ ejiri Glucofage.
Danazole na-ebelata ịdị irè nke ọgwụ, na-abawanye ọkwa shuga na ndị ọrịa mamịrị. Chlorpromazine, glucocorticosteroids, beta2-adrenergic agonists na “loop” diuretics na-esokwa na-abawanye na glycemia.
Ọ bụrụ na ị were Glucophage na ego ndị a dị n'elu, onye ọrịa ahụ kwesịrị ilebara ihe glucose dị n'ọbara anya.
Usoro ọgwụgwọ ndị ọzọ nwere ike, na ntụle, na-eme ka mmetụta glucose na-ebelata Glucofage. Ndị a gụnyere ACE inhibitors, nifedipine, acarbose, sulfonylureas, salicylates na insulin. Okwesiri iburu n'uche na "akpo" diuretics bu ihe na-akpata mmepe nke lactic acidosis megide ndabere nke odida akuko. Na mgbakwunye, ọgwụ cationic na-abawanye mkpokọta nke metformin, si otú ahụ na-akpalite hypoglycemia.
Mgbe ị na-eji ego ndị a, ọ dị mkpa ịgbaso ndụmọdụ nke dibịa na-aga.
Ileghara ọbụna otu iwu anya nwere ike ibute nsonaazụ dị egwu, ruo na glycemic coma.
Ngwakọta anaghị atụ aro ya na Glucofage
Site na nzaghachi sitere na ndị ọrịa nwere ọrịa shuga, ọ ga-ekwe omume ikpokọta ndepụta ọgwụ nwere ike inwe mmetụta ụfọdụ na ọkwa glucose.
Lorista N bụ ọgwụ nwere ike ibute ọbara mgbali elu ma gbochie mmepe nke ọrịa obi. Agaghị akwado Lorist maka iji Glucophage.
Ndị ọrịa mamịrị nwere ọrịa imeju kwesịrị iji ọgwụ Phenibut mee ọgwụ nke ọma, nke na-enyere aka wepu iche iche na ọnọdụ asthenic.
Atarax bu ogwu nke nwere ogwu mgbochi ma na akpochichaa ihe. Enweghị njikọ dị n'etiti ọkwa glucose na nsonaazụ nke ọgwụ. Agbanyeghị, Atarax adịghị ejikọ ya na ịnwe mkpụrụ ndụ ihe nketa na galactose.
Arifon Retard bụ ọgwụ eji agbada ọbara mgbali elu. Ntụziaka agbakwunyere kwuru na ekwesịrị ị drugụ ọgwụ ahụ na ọrịa shuga na-akpachapụ anya.
Fluoxetine bụ ọgwụ eji eme ihe maka nsogbu aghara-aghara na oke ụjọ neurosis.
Ojiji nke glucophage na fluoxetine nwere ike imetụta ọkwa glucose na njọ.
Ọgwụ
Agbanyeghị, enwere otutu ọgwụ na agwakọta Glucophage. Iji maa atụ, Nasonex bụ ọgwụ dị n'ụdị ịgba. A na-eji Nasonex mee ihe maka rhinitis n'oge a kara aka na nke oge a, sinusitis, rhinosinusitis, polyposis nke imi na mgbochi nke rhinitis nfụkasị. Anabataghị Nasonex ọ bụghị naanị maka ndị okenye, kamakwa maka ụmụaka karịa afọ 12. Nasonex enweghị ọrịa contraindications nke metụtara ọrịa shuga. Ya mere, ndị ọrịa nwere ike iji Nasonex maka oyi na mmeghachi ahụ nfụkasị.
Noliprel bụ ọgwụ eji alụ ọgụ ọbara mgbali dị mkpa na igbochi ọrịa obi, ọkachasị ndị ọrịa nwere ọrịa shuga 2 na oke mgbali.
Alflutop bụ ọgwụ amịpụtara n’ụdị ampoules maka nchịkwa intramuscular na intraarticular. Edere Alflutop maka osteoarthritis, osteochondrosis, periarthritis, osteomyelitis maka ọrịa shuga mellitus na nsogbu ndị ọzọ nke kọlụm azụ na nkwonkwo. Ngwá ọrụ a na-ezo aka na chondroprotector. Alflutop na-eme ka usoro metabolic dị na uto, na-eme ka collagen nwee mmetụta na-egbochi mbufụt. Na mgbakwunye, Alflutop nwere mmetụta nyocha dị mma. Nyocha nke ọtụtụ ndị ọrịa mamịrị banyere ọgwụ Alflutop na-egosi na arụmọrụ ya na ndakọrịta zuru oke na Glucofage.
- Mummy bụ onye na-ahụ maka protinlactic maka mmepe nke ọrịa na-efe efe, iji belata ọnya ọbara na ọgwụgwọ ngwa ngwa nke mgbaji. Mmekorita ya na Glucophage anaghị eduga na nsonaazụ ọ bụla.
- A na-eji Human Chorionic Gonadotropin (hCG) mee ihe maka ọrịa hormonal dị iche iche na ụmụ nwoke na ụmụ nwanyị.
- Iodomarin bụ ọgwụ na-egbochi mmepe nke goemat endemic.
Enwere ike iji ọgwụ mgbochi dịgasị iche na Glucofage, ọ bụ ezie na mgbe ejiri ọgwụ hypoglycemic ndị ọzọ, ha nwere ike imetụta ọkwa shuga.
O di nwute, enweghi ogwu di otu a na adighi emetuta ndu ogwu ozo. Yabụ, n'ịgwọ ọrịa na-efe efe, onye na-arịa ọrịa shuga ga-a drugụ ọgwụ ahụ naanị n'ọnọdụ ma ọ bụrụ na ngwakọta dị otú ahụ adịghị mma ma ọ dịghị eweta mmerụ ahụ ọ bụla.
Ọkachamara si na vidiyo dị n'isiokwu a ga-ekwu maka Glucofage na mmetụta hypoglycemic ya.
